NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球細胞和基因治療市場——到 2030 年的機遇和策略:COVID-19 的影響和變化

Cell and Gene Therapy market Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

出版商 The Business Research Company 商品編碼 1014704
出版日期 內容資訊 英文 282 Pages
商品交期: 2-3個工作天內
價格
全球細胞和基因治療市場——到 2030 年的機遇和策略:COVID-19 的影響和變化 Cell and Gene Therapy market Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
出版日期: 2021年06月16日內容資訊: 英文 282 Pages
簡介

本報告調查了全球細胞和基因治療市場,包括市場規模和預測、增長和製約因素、COVID-19 的影響、競爭形勢、市場份額、市場趨勢和策略、產品和我們提供的信息,例如市場按應用/地區/國家和主要公司簡介進行分析。

目錄

細胞和基因治療市場的第 1 章執行摘要

第二章目錄

第 3 章圖列表

第4章表格列表

第五章報告結構

第 6 章介紹

  • 區域細分
  • 按產品細分
  • 按應用細分

第 7 章細胞和基因治療市場的特徵

  • 按產品細分
    • 細胞療法
    • 基因治療
  • 按應用細分
    • 腫瘤
    • 神經障礙
    • 其他

第8章細胞和基因治療的市場趨勢和策略

  • 嵌合抗原受體 (CAR) T 細胞療法
  • 世界研究計劃和資助
  • 先進技術在細胞和基因治療中的整合
  • 越來越關注基因編輯
  • 增加合作夥伴關係和收購以促進細胞和基因治療
  • 越來越多的管道研究和藥物開發
  • 擴大投資和擴大製造設施

第 9 章 COVID-19 對細胞和基因治療市場的影響

  • 簡介
  • 對製造和商業活動的影響
  • COVID-19 對治療的影響
  • 藥物治療
  • 結論

第 10 章全球細胞和基因治療市場規模和增長

  • 市場規模
  • 市場增長 (2015-2020) 銷售額
    • 市場增長因素(2015-2020)
    • 市場限制(2015-2020)
  • 市場增長預測 (2020-2025, 2030F) 銷售額
    • 市場增長因素(2020-2025)
    • 市場限制(2020-2025)

第11章全球細胞和基因治療市場的細分

  • 全球細胞和基因治療市場、產品細分、性能和預測(2015-2020、2025F、2030F)銷售額
    • 基因治療
    • 細胞療法
  • 全球細胞和基因治療市場、特定應用細分、性能和預測(2015-2020、2025F、2030F)銷售額
    • 腫瘤
    • 神經障礙
    • 其他

第 12 章細胞和基因治療市場、區域和國家分析

  • 全球細胞和基因治療市場、區域、性能和預測(2015-2020、2025F、2030F)銷售額
  • 全球細胞和基因治療市場、國家、業績和預測(2015-2020、2025F、2030F)銷售額

第13章亞太細胞和基因治療市場

  • 亞太地區細胞和基因治療市場概覽
    • 區域信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 市場增長 (2015-2020) 銷售額
  • 市場增長預測 (2020-2025, 2030F) 銷售額
  • 產品細分、結果和預測(2015-2020、2025F、2030F)銷售額
  • 按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 國家分析
  • 中國細胞和基因治療市場
  • 中國細胞和基因治療市場概況
    • 國家信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 中國:市場增長(2015-2020)銷售額
  • 中國:市場增長預測(2020-2025,2030F)銷售額
  • 中國:按產品、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 中國:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 印度細胞和基因治療市場
  • 印度細胞和基因治療市場概覽
    • 國家信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 減稅
    • 公司稅收結構
    • 投資
    • 大公司
  • 印度:市場增長(2015-2020)銷售額
  • 印度:市場增長預測(2020-2025,2030F)銷售額
  • 印度:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 印度:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 日本細胞和基因治療市場
  • 日本細胞和基因治療市場概覽
    • 國家信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 減稅
    • 公司稅收結構
    • 投資
    • 大公司
  • 日本:市場增長(2015-2020)銷售額
  • 日本:市場增長預測(2020-2025、2030F)銷售額
  • 日本:按產品、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 日本:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 澳大利亞細胞和基因治療市場
  • 澳大利亞:市場增長(2015-2020)銷售額
  • 澳大利亞:市場增長預測(2020-2025、2030F)銷售額
  • 澳大利亞:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 澳大利亞:按應用、性能和預測(2015-2020、2025F、2030F)銷售細分
  • 印度尼西亞細胞和基因治療市場
  • 印度尼西亞:市場增長預測(2020-2025、2030F)銷售額
  • 印度尼西亞:產品細分、結果和預測(2015-2020、2025F、2030F)銷售
  • 印度尼西亞:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 韓國細胞和基因治療市場
  • 韓國:市場增長(2015-2020)銷售額
  • 韓國:市場增長預測(2020-2025、2030F)銷售額
  • 韓國:產品細分、結果和預測(2015-2020、2025F、2030F)銷售
  • 韓國:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額

第14章西歐細胞和基因治療市場

  • 西歐細胞和基因治療市場概覽
    • 區域信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 市場增長 (2015-2020) 銷售額
  • 市場增長預測 (2020-2025, 2030F) 銷售額
  • 產品細分、結果和預測(2015-2020、2025F、2030F)銷售額
  • 按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 國家分析
  • 英國細胞和基因治療市場
  • 英國細胞和基因治療市場概覽
    • 國家信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 英國:市場增長(2015-2020)銷售額
  • 英國:市場增長預測(2020-2025、2030F)銷售額
  • 英國:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 英國:按應用、實際和預測(2015-2020、2025F、2030F)銷售額細分
  • 德國細胞和基因治療市場
  • 德國:市場增長(2015-2020)銷售額
  • 德國:市場增長預測(2020-2025,2030F)銷售額
  • 德國:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 德國:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 法國細胞和基因治療市場
  • 法國:市場增長(2015-2020)銷售額
  • 法國:市場增長預測(2020-2025、2030F)銷售額
  • 法國:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 法國:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額

第15章東歐細胞和基因治療市場

  • 東歐細胞和基因治療市場概覽
    • 區域信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 市場增長 (2015-2020) 銷售額
  • 市場增長預測 (2020-2025, 2030F) 銷售額
  • 產品細分、結果和預測(2015-2020、2025F、2030F)銷售額
  • 按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 國家分析
  • 俄羅斯細胞和基因治療市場
  • 俄羅斯:市場增長(2015-2020)銷售額
  • 俄羅斯:市場增長預測(2020-2025、2030F)銷售額
  • 俄羅斯:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 俄羅斯:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額

第16章北美細胞和基因治療市場

  • 北美細胞和基因治療市場概覽
    • 區域信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 市場增長 (2015-2020) 銷售額
  • 市場增長預測 (2020-2025, 2030F) 銷售額
  • 產品細分、結果和預測(2015-2020、2025F、2030F)銷售額
  • 按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 國家分析
  • 美國細胞和基因治療市場
  • 美國細胞和基因治療市場概覽
    • 國家信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 美國:市場增長(2015-2020)銷售額
  • 美國:市場增長預測(2020-2025、2030F)銷售額
  • 美國:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 美國:按應用、實際和預測(2015-2020、2025F、2030F)銷售額細分

第17章南美細胞和基因治療市場

  • 南美細胞和基因治療市場概覽
    • 區域信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 已收稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 市場增長 (2015-2020) 銷售額
  • 市場增長預測 (2020-2025, 2030F) 銷售額
  • 產品細分、結果和預測(2015-2020、2025F、2030F)銷售額
  • 按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額
  • 國家分析
  • 巴西細胞和基因治療市場
  • 巴西:市場增長(2015-2020)銷售額
  • 巴西:市場增長預測(2020-2025、2030F)銷售額
  • 巴西:產品細分、性能和預測(2015-2020、2025F、2030F)銷售
  • 巴西:按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額

第18章中東細胞和基因治療市場

  • 中東細胞和基因治療市場概覽
    • 區域信息
    • COVID-19 的影響
    • 市場信息
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 主要協會
    • 應徵收的稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 市場增長 (2015-2020) 銷售額
  • 市場增長預測 (2020-2025, 2030F) 銷售額
  • 產品細分、結果和預測(2015-2020、2025F、2030F)銷售額
  • 按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額

第 19 章非洲細胞和基因治療市場

  • 非洲細胞和基因治療市場概覽
    • 區域信息
    • COVID-19 的影響
    • 背景信息
    • 政府倡議
    • 規則
    • 監管機構
    • 協會
    • 應徵收的稅款
    • 公司稅收結構
    • 投資
    • 大公司
  • 市場增長預測 (2020-2025, 2030F) 銷售額
  • 產品細分、結果和預測(2015-2020、2025F、2030F)銷售額
  • 按應用、實際結果和預測細分(2015-2020、2025F、2030F)銷售額

第20章全球細胞和基因治療市場的競爭態勢

  • 公司簡介
  • 百健公司
    • 公司簡介
    • 產品/服務
    • 經營戰略
    • 財務概覽
  • 諾華公司
    • 公司簡介
    • 產品/服務
    • 經營戰略
    • 財務概覽
  • 吉利德科學公司
    • 公司簡介
    • 產品/服務
    • 經營戰略
    • 財務概覽
  • Ionis Pharmaceuticals, Inc.
    • 公司簡介
    • 產品/服務
    • 經營戰略
    • 財務概覽
  • Alnylam Pharmaceuticals, Inc.
    • 公司簡介
    • 產品/服務
    • 經營戰略
    • 財務概覽

第21章細胞和基因治療市場的重大併購

  • Thermo Fisher Scientific 以 8.7576 億美元從 Novasep 手中收購了病毒載體業務
  • 安斯泰來以 30 億美元收購 Audentes Therapeutics
  • 羅氏以 48 億美元收購 Spark Therapeutics Incorporated
  • Vertex 以 9.5 億美元收購 Semma Therapeutics
  • 拜耳以 10 億美元收購 BlueRock Therapeutics
  • Biogen 以 8 億美元收購 Nightstar Therapeutics
  • Catalent 以 12 億美元收購 Paragon Bioservices Incorporated
  • 諾華以 87 億美元收購 AveXis

第 22 章細胞和基因治療市場機會和策略

  • 2025 年全球細胞和基因治療市場——提供最新機遇的國家
  • 2025 年全球細胞和基因治療市場提供最新機遇
  • 2025 年全球細胞和基因治療市場-增長戰略
    • 基於市場趨勢的策略
    • 競爭戰略

第 23 章細胞和基因治療市場,結論/建議

  • 結論
  • 推薦

第24章附錄

目錄
Product Code: o&s245

Cell and Gene Therapy Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cell and gene therapy market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cell and gene therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cell and gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cell and gene therapy market, and compares it with other markets.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type and by interest rate.

Market Characteristics - The market characteristics section of the report defines and explains the cell and gene therapy market. This chapter also defines and describes goods and related services covered in the report.

Supply Chain - The supply chain section of the report defines and explains the key players in the cell and gene therapy industry supply chain.

Product/Service Analysis - The product/service analysis section of the report describes the leading products/services in the cell and gene therapy market along with key features and differentiators for those products/services.

Customer Information - This chapter covers recent customers' trends/preferences in the global cell and gene therapy market.

Trends And Strategies - This chapter describes the major trends shaping the global cell and gene therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of CoVID-19 - This section describes the impact of COVID-19 on the cell and gene therapy market.

Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2015-2030) and analysis for different segments.

Global Macro Comparison - The global cell and gene therapy market comparison with macro-economic factors gives the cell and gene therapy market size, percentage of GDP, and average cell and gene therapy market expenditure.

Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global cell and gene therapy market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Background - This section describes the cell and gene therapy market. This chapter includes the global cell and gene therapy market 2015-19 and 2019-23 values, and regional analyses for the cell and gene therapy market.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for cell and gene therapy companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered: 1) By Product: Cell Therapy; Gene Therapy

2) By Application: Oncology; Neurological Disorders; Others

Companies Mentioned: Biogen Inc.; Novartis AG; Gilead Sciences; Ionis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals Inc.

Metrics Covered: Number of Enterprises; Number of Employees

Countries: USA; China; Japan; Germany; France; UK; Russia; India; Brazil; Australia; South Korea; Indonesia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cell and gene therapy indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Cell And Gene Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By Product
  • 6.3. Segmentation By Application

7. Cell And Gene Therapy Market Characteristics

  • 7.1. Segmentation By Product
    • 7.1.1.Cell Therapy
    • 7.1.2.Gene Therapy
  • 7.2. Segmentation By Application
    • 7.2.1.Oncology
    • 7.2.2.Neurological Disorders
    • 7.2.3.Others

8. Cell And Gene Therapy Market Trends And Strategies

  • 8.1. Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • 8.2. Global Research Initiatives And Funding
  • 8.3. Integration Of Advanced Technologies In Cell And Gene Therapies
  • 8.4. Rising Focus On Gene Editing
  • 8.5. Increasing Partnerships And Acquisitions For Promoting Cell And Gene Therapies
  • 8.6. Increasing Number Of Pipeline Studies And Drug Development
  • 8.7. Growing Investments and Manufacturing Facility Expansion

9. Impact Of COVID-19 On The Cell And Gene Therapy Market

  • 9.1. Introduction
  • 9.2. Impact On Manufacturing And Commercial Operations
  • 9.3. COVID-19 Impact On Treatment
  • 9.4. Drug Therapies
  • 9.5. Conclusion

10. Global Cell And Gene Therapy Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2020
    • 10.2.2. Restraints On The Market 2015 - 2020
  • 10.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
    • 10.3.1. Drivers Of The Market 2020 - 2025
    • 10.3.2. Restraints On The Market 2020 - 2025

11. Global Cell And Gene Therapy Market Segmentation

  • 11.1. Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 11.1.1. Gene Therapy
    • 11.1.2. Cell Therapy
  • 11.2. Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 11.2.1. Oncology
    • 11.2.2. Neurological Disorders
    • 11.2.3. Others

12. Cell And Gene Therapy Market, Regional And Country Analysis

  • 12.1. Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Cell And Gene Therapy Market

  • 13.1. Asia-Pacific Cell And Gene Therapy Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Impact of COVID-19
    • 13.1.3. Market Information
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes Levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investments
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.3. Asia-Pacific Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.4. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.5. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.6. Asia-Pacific Cell And Gene Therapy Market: Country Analysis
  • 13.7. China Cell And Gene Therapy Market
  • 13.8. China Cell And Gene Therapy Market Overview
    • 13.8.1. Country Information
    • 13.8.2. Impact of COVID-19
    • 13.8.3. Market Information
    • 13.8.4. Background Information
    • 13.8.5. Government Initiatives
    • 13.8.6. Regulations
    • 13.8.7. Regulatory Bodies
    • 13.8.8. Major Associations
    • 13.8.9. Taxes Levied
    • 13.8.10. Corporate Tax Structure
    • 13.8.11. Investments
    • 13.8.12. Major Companies
  • 13.9. China Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.10. China Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.11. China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.12. China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.13. India Cell And Gene Therapy Market
  • 13.14. India Cell And Gene Therapy Market Overview
    • 13.14.1. Country Information
    • 13.14.2. Impact of COVID-19
    • 13.14.3. Market Information
    • 13.14.4. Background Information
    • 13.14.5. Government Initiatives
    • 13.14.6. Regulations
    • 13.14.7. Regulatory Bodies
    • 13.14.8. Major Associations
    • 13.14.9. Tax Levied
    • 13.14.10. Corporate Tax Structure
    • 13.14.11. Investments
    • 13.14.12. Major Companies
  • 13.15. India Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.16. India Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.17. India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.18. India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.19. Japan Cell And Gene Therapy Market
  • 13.20. Japan Cell And Gene Therapy Market Overview
    • 13.20.1. Country Information
    • 13.20.2. Impact of COVID-19
    • 13.20.3. Market Information
    • 13.20.4. Background Information
    • 13.20.5. Government Initiatives
    • 13.20.6. Regulations
    • 13.20.7. Regulatory Bodies
    • 13.20.8. Major Associations
    • 13.20.9. Tax Levied
    • 13.20.10. Corporate Tax Structure
    • 13.20.11. Investments
    • 13.20.12. Major Companies
  • 13.21. Japan Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.22. Japan Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.23. Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.24. Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.25. Australia Cell And Gene Therapy Market
  • 13.26. Australia Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.27. Australia Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.28. Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.29. Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.30. Indonesia Cell And Gene Therapy Market
  • 13.31. Indonesia Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.32. Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.33. Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.34. South Korea Cell And Gene Therapy Market
  • 13.35. South Korea Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.36. South Korea Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 13.37. South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 13.38. South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Cell And Gene Therapy Market

  • 14.1. Western Europe Cell And Gene Therapy Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Impact Of COVID-19
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.3. Western Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.4. Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.5. Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.6. Western Europe Cell And Gene Therapy Market: Country Analysis
  • 14.7. UK Cell And Gene Therapy Market
  • 14.8. UK Cell And Gene Therapy Market Overview
    • 14.8.1. Country Information
    • 14.8.2. Impact Of COVID-19
    • 14.8.3. Market Information
    • 14.8.4. Background Information
    • 14.8.5. Government Initiatives
    • 14.8.6. Regulations
    • 14.8.7. Regulatory Bodies
    • 14.8.8. Major Associations
    • 14.8.9. Taxes Levied
    • 14.8.10. Corporate Tax Structure
    • 14.8.11. Investments
    • 14.8.12. Major Companies
  • 14.9. UK Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.10. UK Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.11. UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.12. UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.13. Germany Cell And Gene Therapy Market
  • 14.14. Germany Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.15. Germany Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.16. Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.17. Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.18. France Cell And Gene Therapy Market
  • 14.19. France Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.20. France Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 14.21. France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 14.22. France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Cell And Gene Therapy Market

  • 15.1. Eastern Europe Cell And Gene Therapy Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Impact Of COVID-19
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.3. Eastern Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 15.4. Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.5. Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.6. Eastern Europe Cell And Gene Therapy Market: Country Analysis
  • 15.7. Russia Cell And Gene Therapy Market
  • 15.8. Russia Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.9. Russia Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 15.10. Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 15.11. Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America Cell And Gene Therapy Market

  • 16.1. North America Cell And Gene Therapy Market Overview
    • 16.1.1. Region Information
    • 16.1.2. COVID-19 Impact
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Regulations
    • 16.1.6. Regulatory Bodies
    • 16.1.7. Major Associations
    • 16.1.8. Taxes Levied
    • 16.1.9. Corporate Tax Structure
    • 16.1.10. Investments
    • 16.1.11. Major Companies
  • 16.2. North America Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.3. North America Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 16.4. North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 16.5. North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 16.6. North America Cell And Gene Therapy Market: Country Analysis
  • 16.7. USA Cell And Gene Therapy Market
  • 16.8. USA Cell And Gene Therapy Market Overview
    • 16.8.1. Country Information
    • 16.8.2. COVID-19 Impact
    • 16.8.3. Market Information
    • 16.8.4. Background Information
    • 16.8.5. Government Initiatives
    • 16.8.6. Regulations
    • 16.8.7. Regulatory Bodies
    • 16.8.8. Major Associations
    • 16.8.9. Taxes Levied
    • 16.8.10. Corporate Tax Structure
    • 16.8.11. Investments
    • 16.8.12. Major Companies
  • 16.9. USA Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.10. USA Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 16.11. USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 16.12. USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America Cell And Gene Therapy Market

  • 17.1. South America Cell And Gene Therapy Market Overview
    • 17.1.1. Region Information
    • 17.1.2. COVID-19 Impact
    • 17.1.3. Market Information
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.3. South America Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.4. South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.5. South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.6. South America Cell And Gene Therapy Market: Country Analysis
  • 17.7. Brazil Cell And Gene Therapy Market
  • 17.8. Brazil Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.9. Brazil Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 17.10. Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 17.11. Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Cell And Gene Therapy Market

  • 18.1. Middle East Cell And Gene Therapy Market Overview
    • 18.1.1. Region Information
    • 18.1.2. COVID-19 Impact
    • 18.1.3. Market Information
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Cell And Gene Therapy Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.3. Middle East Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 18.4. Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 18.5. Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa Cell And Gene Therapy Market

  • 19.1. Africa Cell And Gene Therapy Market Overview
    • 19.1.1. Regional Information
    • 19.1.2. COVID-19 Impact
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Associations
    • 19.1.8. Taxes levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Africa Cell And Gene Therapy Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
  • 19.3. Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 19.4. Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global Cell And Gene Therapy Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Biogen Inc.
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Novartis AG
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Gilead Sciences, Inc.
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. Ionis Pharmaceuticals, Inc.
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Alnylam Pharmaceuticals, Inc.
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Cell And Gene Therapy Market

  • 21.1. Thermo Fisher Scientific Acquired Viral Vector Business From Novasep for $875.76 million
  • 21.2. Astellas Acquired Audentes Therapeutics for $3 billion
  • 21.3. Roche Acquired Spark Therapeutics Incorporated for $4.8 billion
  • 21.4. Vertex Acquired Semma Therapeutics for $950 million
  • 21.5. Bayer Acquired BlueRock Therapeutics for $1 billion
  • 21.6. Biogen Acquired Nightstar Therapeutics for $800 million
  • 21.7. Catalent Acquired Paragon Bioservices Incorporated for $1.2 billion
  • 21.8. Novartis Acquired AveXis for $8.7 billion

22. Cell And Gene Therapy Market Opportunities And Strategies

  • 22.1. Global Cell And Gene Therapy Market In 2025 - Countries Offering Most New Opportunities
  • 22.2. Global Cell And Gene Therapy Market In 2025 - Segments Offering Most New Opportunities
  • 22.3. Global Cell And Gene Therapy Market In 2025 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Cell And Gene Therapy Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Price
    • 23.2.3. Place
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer